ATYR vs SRPT · rev $190.0K vs rev $1.13B
aTyr Pharma, Inc. (ATYR) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
ATYR currently screens at market cap $471.7M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the ATYR and SRPT stock pages for the full models.
Not investment advice.